AbbVie (ABBV) receives $260 mark goal upgrades from Citi and UBS, however Neutral ratings persist as Zacks flags Promote and valuation considerations emerge.
The put up AbbVie (ABBV) Will get $260 Mark Goal Upgrades Amid Rising Valuation Worries seemed first on Blockonomi…
Read More
AbbVie (ABBV) Will get $260 Mark Goal Upgrades Amid Rising Valuation Worries
